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Counselling for Alcohol Problems (CAP), a lay counsellor-
delivered brief psychological treatment for harmful drinking 
in men, in primary care in India: a randomised controlled trial
Abhijit Nadkarni*, Benedict Weobong*, Helen A Weiss, Jim McCambridge, Bhargav Bhat, Basavaraj Katti, Pratima Murthy, Michael King, 
David McDaid, A-La Park, G Terence Wilson, Betty Kirkwood, Christopher G Fairburn, Richard Velleman†, Vikram Patel†
Summary
Background Although structured psychological treatments are recommended as ﬁ rst-line interventions for harmful 
drinking, only a small fraction of people globally receive these treatments because of poor access in routine primary care. 
We assessed the eﬀ ectiveness and cost-eﬀ ectiveness of Counselling for Alcohol Problems (CAP), a brief psychological 
treatment delivered by lay counsellors to patients with harmful drinking attending routine primary health-care settings.
Methods In this randomised controlled trial, we recruited male harmful drinkers deﬁ ned by an Alcohol Use Disorders 
Identiﬁ cation Test (AUDIT) score of 12–19 who were aged 18–65 years from ten primary health centres in Goa, India. We 
excluded patients who needed emergency medical treatment or inpatient admission, who were unable to communicate 
clearly, and who were intoxicated at the time of screening. Participants were randomly allocated (1:1) by trained health 
assistants based at the primary health centres to enhanced usual care (EUC) alone or EUC combined with CAP, in 
randomly sized blocks of four to six, stratiﬁ ed by primary health centre, and allocation was concealed with use of sequential 
numbered opaque envelopes. Physicians providing EUC and those assessing outcomes were masked. Primary outcomes 
were remission (AUDIT score of <8) and mean daily alcohol consumed in the past 14 days, at 3 months. Secondary 
outcomes were the eﬀ ect of drinking, disability score, days unable to work, suicide attempts, intimate partner violence, 
and resource use and costs of illness. Analyses were on an intention-to-treat basis. We used logistic regression analysis for 
remission and zero-inﬂ ated negative binomial regression analysis for alcohol consumption. We assessed serious adverse 
events in the per-protocol population. This trial is registered with the ISCRTN registry, number ISRCTN76465238. 
Findings Between Oct 28, 2013, and July 29, 2015, we enrolled and randomly allocated 377 participants (188 [50%] to the 
EUC plus CAP group and 190 [50%] to the EUC alone group [one of whom was subsequently excluded because of a 
protocol violation]), of whom 336 (89%) completed the 3 month primary outcome assessment (164 [87%] in the EUC 
plus CAP group and 172 [91%] in the EUC alone group). The proportion with remission (59 [36%] of 164 in the EUC plus 
CAP group vs 44 [26%] of 172 in the EUC alone group; adjusted prevalence ratio 1·50 [95% CI 1·09–2·07]; p=0·01) and 
the proportion abstinent in the past 14 days (68 [42%] vs 31 [18%]; adjusted odds ratio 3·00 [1·76–5·13]; p<0·0001) were 
signiﬁ cantly higher in the EUC plus CAP group than in the EUC alone group, but we noted no eﬀ ect on mean daily 
alcohol consumed in the past 14 days among those who reported drinking in this period (37·0 g [SD 44·2] vs 31·0 g [27·8]; 
count ratio 1·08 [0·79–1·49]; p=0·62). We noted an eﬀ ect on the percentage of days abstinent in the past 14 days (adjusted 
mean diﬀ erence [AMD] 16·0% [8·1–24·1]; p<0·0001), but no eﬀ ect on the percentage of days of heavy drinking 
(AMD –0·4% [–5·7 to 4·9]; p=0·88), the eﬀ ect of drinking (Short Inventory of Problems score AMD–0·03 [–1·93 to 1·86]; 
p=0.97), disability score (WHO Disability Assessment Schedule score AMD 0·62 [–0·62 to 1·87]; p=0·32), days unable to 
work (no days unable to work adjusted odds ratio 1·02 [0·61–1·69]; p=0.95), suicide attempts (adjusted prevalence 
ratio 1·8 [–2·4 to 6·0]; p=0·25), and intimate partner violence (adjusted prevalence ratio 3·0 [–10·4 to 4·4]; p=0·57). The 
incremental cost per additional remission was $217 (95% CI 50–1073), with an 85% chance of being cost-eﬀ ective in the 
study setting. We noted no signiﬁ cant diﬀ erence in the number of serious adverse events between the two groups 
(six [4%] in the EUC plus CAP group vs 13 [8%] in the EUC alone group; p=0·11). 
Interpretation CAP delivered by lay counsellors plus EUC was better than EUC alone was for harmful drinkers in 
routine primary health-care settings, and might be cost-eﬀ ective. CAP could be a key strategy to reduce the treatment 
gap for alcohol use disorders, one of the leading causes of the global burden among men worldwide.
Funding Wellcome Trust.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.
Introduction
Alcohol use disorders comprise various conditions 
related to excessive alcohol consumption, with hazardous 
drinking, harmful drinking, and dependent drinking 
reﬂ ecting progressively more serious forms.1 Alcohol use 
disorders contribute substantially to disability and 
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premature mortality, accounting for 7·9% (95% CI 6–10) 
of years lost to disability and 44·4% (29·1–60·0) of years 
of life lost because of all mental and substance use 
disorders.2 Among men in middle-income countries, 
alcohol use disorders are the leading neuropsychiatric 
cause of disease burden.3 In India, alcohol-attributable 
mortality and prevalence of alcohol use disorders relative 
to the per-person volume of alcohol consumed are high.1
Hazardous (a quantity or pattern of alcohol con-
sumption that places individuals at risk of physical or 
psychological harm) and harmful (a quantity or pattern 
of alcohol consumption that has resulted in physical or 
psychological harm) drinking4 aﬀ ect more people than 
does dependent drinking5 (a quantity or pattern of alcohol 
consumption characterised by craving, tolerance, a 
preoccupation with alcohol, and continued drinking 
despite harmful consequences),6 but the policy response 
to the growing public health problem of alcohol use 
disorders in low-income and middle-income countries 
remains focused on dependent drinking.5
Various psychosocial interventions are available for 
treatment of alcohol use disorders and can be broadly 
summarised as follows. Brief interventions are short, 
typically a single session lasting up to 15 min, focused on 
psychosocial interventions designed to address alcohol-
related problems or reduce heavy drinking in hazardous 
drinkers.7 Severe alcohol problems, such as harmful 
drinking, require specialised brief or extended therapies 
(eg, behavioural therapy, motivational enhancement 
therapy, or Twelve Step Facilitation).8 Although brief 
psychological interventions are recommended for harmful 
drinking by the recent Disease Control Priorities Project9 
(a project aimed at compilation and dis semination of the 
most up-to-date evidence for cost-eﬀ ective interventions 
and their delivery for the leading causes of global disease 
burden), most people in low-income and middle-income 
countries, including India, lack access to such inter-
ventions because of the absence of skilled human 
resources10 and concerns regarding the contextual 
appropriate ness and generalisability of inter ventions 
developed in high-income cultural settings.11,12 These 
barriers could be addressed by development and testing of 
interventions that have been matched to the context in 
which they will be oﬀ ered and delivery of them via non-
specialist health workers (NSHWs) or counsellors.13
PREMIUM (Program for Eﬀ ective Mental Health 
Interventions in Under-Resourced Health Systems) is a 
research programme whose goal was to design methods 
for development and assessment of scalable psychological 
treatments that are culturally appropriate, aﬀ ordable, and 
feasible for delivery by NSHWs and to apply these 
methods14 to depression (the Healthy Activity Program 
[HAP])15 and harmful drinking (Counselling for Alcohol 
Problems [CAP]).16 In this Article, we describe the results 
of a trial assessing the eﬀ ectiveness and cost-eﬀ ectiveness 
of the CAP treatment when used in primary care. The 
study of HAP treatment is reported separately.17 The two 
trials of HAP and CAP were done concurrently in the 
same primary health centres (PHCs) and over the same 
period of time, with the same counsellors delivering both 
treatments according to the trial allocations of participants.
Methods
Study design and participants
In this randomised controlled trial, we recruited 
participants from PHCs in Goa, India. Of the 14 PHCs in 
Research in context
Evidence before this study
We updated WHO’s Mental Health Gap Action Programme 
systematic review with our own systematic review. We searched 
the PubMed, PsycINFO, and IndMed databases from Jan 1, 1990, 
to Jan 1, 2011, for English language publications using the 
following search terms: “alcohol”, “drinking”, “addiction”, 
“psychological”, “therapy”, “counselling”, and “treatment”. Brief 
psychological treatments based on motivational enhancement 
have been shown to be eﬀ ective for management of harmful 
drinking and are recommended as ﬁ rst-line interventions by 
WHO’s Mental Health Gap Action Programme for delivery in 
routine health-care settings. However, the existing evidence has 
low generalisability to many low-income and middle-income 
countries where both supply side barriers (low availability of 
mental health professionals) and demand side barriers (low levels 
of mental health literacy) lead to large treatment gaps.
Added value of this study
This study reports the ﬁ rst ﬁ ndings from any low-income and 
middle-income country assessing the eﬀ ectiveness and 
cost-eﬀ ectiveness of a brief psychological treatment for harmful 
drinking, delivered by lay counsellors in primary care. The brief (up 
to four-session) psychological treatment (Counselling for Alcohol 
Problems), based on motivational enhancement, with additional 
behavioural and cognitive elements, was better than was 
enhanced usual care according to all prespeciﬁ ed primary clinical 
outcomes, except for mean daily alcohol consumed in the past 
14 days among those who reported drinking in this period, but no 
eﬀ ect occurred on social and functional outcomes. The treatment 
was readily accepted by this previously untreated population and 
was highly likely to be cost-eﬀ ective in this setting.
Implications of all the available evidence
Brief psychological treatments for harmful drinking, based on 
motivational enhancement, are acceptable, feasible, and 
cost-eﬀ ective, even when delivered by non-specialist health 
workers in routine health-care settings in previously untreated 
populations. Such treatments should be scaled up as one of the 
key strategies to address the large and rising global burden of 
alcohol use disorders. 
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the north district of Goa, the Directorate of Health 
Services gave permission for PREMIUM to operate in 
ten. We started screening in eight, but during the course 
of the trial, two of these PHCs were replaced as one had 
low attendance and the other had a large proportion of 
migrant labourers. So at any given time, screening was 
only happening in eight PHCs. The publicly funded 
PHCs are the ﬁ rst option for people seeking health care 
in the public system in India. The population served 
generally belongs to low socioeconomic groups.
Participants were 18–65-year-old men (women were not 
eligible as prevalence of any drinking in women in India 
is low, at 1%18) who were likely to be harmful drinkers, 
deﬁ ned as scoring 12–19 on the Alcohol Use Disorders 
Identiﬁ cation Test (AUDIT).19 We also included harmful 
drinkers who screened positive for depression according 
to the Patient Health Questionnaire 9 (PHQ-9) in this 
trial; we oﬀ ered HAP treatment to those who continued 
to screen positive for depression at the end of CAP 
treatment. Although we did oﬀ er people with alcohol 
dependence (ie, those who scored higher than 20) the 
opportunity to participate in the trial, this action was 
taken primarily to enhance the acceptability of the 
programme in the PHCs; as the trial was not powered for 
outcomes in this opportunistically identiﬁ ed group, the 
ﬁ ndings are not reported here. We excluded from 
screening patients who needed emergency medical 
treatment or inpatient admission, who were unable to 
communicate clearly, and who were intoxicated at the 
time of screening.
The trial protocol20 was approved by the Trial Steering 
Committee, and ethical approval for the conduct of the 
trial was obtained from the Institutional Review Boards 
of the London School of Hygiene & Tropical Medicine, 
Sangath (the imple menting institution in India), and the 
Indian Council of Medical Research. Written (or 
witnessed, if the participant is illiterate) informed 
consent was mandatory for enrolment. We audiotaped all 
consent procedures, with patients’ approvals.
Randomisation and masking
A randomisation list in randomly sized blocks (four to six), 
stratiﬁ ed by PHC, was generated by a statistician 
independent of the trial. The randomisation code was 
concealed and allocated by trained health assistants based 
at the primary health centres at the individual level after 
completion of the baseline assessments using sequential 
numbered opaque sealed envelopes.21 Physicians providing 
enhanced usual care (EUC) were masked to allocation 
status, as were the independent assessors who did the 
outcome assessments, and these people had no contact 
with the PHCs or other team members. All authors, apart 
from the data manager (BB), were masked until the trial 
results were unmasked. Instances of unmasking of 
outcome assessors in the CAP group will be summarised 
on the basis of overall prevalence and the exact point 
during the interview that the interviewer was unmasked.
Procedures
Trained health assistants, independent of the counsellors, 
screened patients using AUDIT and administered a 
baseline questionnaire to trial participants to collect 
sociodemographic information (eg age and marital 
status) and data for potential moderators of treatment 
eﬀ ect. We audiotaped all outcome interviews (with 
permission), and the tapes were randomly selected 
(using a random selection strategy stratiﬁ ed by outcome 
assessor) for review by the supervisor for quality 
assurance.
In the EUC group, usual care (consultation with the 
PHC physician) was enhanced by provision of the 
screening results to the PHC physician and provision of a 
contextualised version of the WHO Mental Health Gap 
Action Programme guidelines22 for harmful drinking, 
including when and where to refer patients for specialist 
care. In the CAP group, participants received EUC plus 
CAP. CAP is a manualised psychological treatment 
delivered in three phases over a maximum of four sessions 
(each lasting approximately 30–45 min) at weekly to 
fortnightly intervals.15 The initial phase involves detailed 
assessment followed by personalised feedback; the middle 
phase involves helping the patient to develop cognitive and 
behavioural skills and techniques, consisting of drink 
refusal skills, handling of peer pressure, problem-solving 
skills, and handling of diﬃ  cult emotions; and the ending 
phase involves the patient learning how to manage 
potential or actual relapses using the skills acquired in the 
middle phase.
The stance adopted by the counsellor is that of 
motivational interviewing23 and client-centred general 
counselling strategies (eg, open-ended questioning and 
showing of empathy). The general counselling and 
problem-solving strategies were shared between CAP 
and HAP treatments. We typically conducted sessions 
face-to-face, at the PHC or patient’s home, but used 
telephone sessions when necessary. We considered 
patients who missed three consecutive scheduled 
sessions to have dropped out of treatment. Counsellors 
were adults with no professional training or qualiﬁ cation 
in the ﬁ eld of mental health, they had completed at least 
secondary school education, and they were ﬂ uent in the 
vernacular languages used in the study settings. The 
selection process began with interviews involving 
roleplays for applicants for the training; for those who 
cleared this step, the process continued with intensive 
2 week classroom training in both CAP and HAP 
treatments, followed by a competency assessment; for 
those who graduated this step, the process continued 
with a 6 month internship with supervision of cases by 
experts; and ﬁ nally, selection occurred through testing of 
knowledge (multiple choice question exam) and skills 
(roleplays with use of standardised vignettes and quality 
ratings of actual CAP sessions delivered). 11 counsellors 
participated in the trial. They received weekly peer-led 
supervision in groups of four to six, which involved 
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rating of a randomly selected (using a random selection 
strategy stratiﬁ ed by counsellor and phase of session) 
10% of recorded sessions on the CAP Therapy Quality 
Scale (TQS)24 and individual supervision twice monthly. 
We used information about contact with the counsellor 
to estimate CAP delivery costs, which took into account 
training, supervision, and salary costs.
We assessed treatment ﬁ delity via treatment completion, 
maintained by counsellors in their clinical records, CAP 
TQS scores from peer and expert ratings of audio 
recordings of sessions during weekly group supervision,24 
and therapy quality of a random selection (using a random 
selection strategy stratiﬁ ed by counsellor and phase of 
session) of 10% of all sessions by an expert involved in the 
development of CAP.
Outcomes
Primary outcomes were remission deﬁ ned as an AUDIT 
score of less than 8 and mean daily alcohol consumption 
in the past 14 days immediately preceding the 3 month 
outcome assessment. We measured the primary 
outcomes 3 months after enrolment. Secondary outcomes 
were the Short Inventory of Problems (SIP) mean score, 
WHO Disability Assessment Schedule (WHODAS) II 
mean disability score, total days unable to work in the 
previous month, a suicide attempt in the past 3 months, 
perpetration of intimate partner violence (“In the past 
3 months, have you slapped, hit, kicked, punched your 
wife/partner or done something else that did or could 
have hurt her physically?”), and resource use and costs of 
illness estimated from the Client Service Receipt 
Inventory.25 SIP mean score was prespeciﬁ ed as a primary 
outcome in the protocol; however, in a joint meeting of 
the Trial Steering Committee and Data Monitoring and 
Safety Committee before unmasking, SIP mean score 
was changed to a secondary outcome to reduce 
multiplicity of the primary outcomes. Two additional 
secondary outcomes that were not prespeciﬁ ed 
(percentage of days abstinent and percentage of days of 
heavy drinking generated from the Timeline Followback) 
were also added to bring the trial in line with 
recommendations of the National Institute on Alcohol 
Abuse and Alcoholism.26 We did outcome assessment 
between Jan 29, 2014, and Nov 30, 2015. We collected data 
for serious adverse events, deﬁ ned as deaths, suicide 
attempts, and unplanned admissions to hospital from 
any cause.
Statistical analysis
Based on the assumptions of participants being randomly 
allocated within each of the clinics, of there being one 
counsellor per PHC at any one time, of an intracluster 
correlation of 0·04, of a loss to follow-up of 15% over 
3 months, and of a 1:1 allocation ratio, a trial size 
of 400 enrolled participants with harmful drinking had 
90% power to detect the hypothesised eﬀ ects (eﬀ ect size 
of 0·45 for mean standard ethanol content consumed; 
remissions of 68% vs 40% in favour of CAP) for the primary 
outcomes, with a 5% type I error. In estimating the sample 
size, we considered both primary outcomes, and the study 
was adequately powered to assess each of these outcomes 
independently. For the binary primary outcome of 
remission, we had a 99% power to detect a remission 
of 68% in the EUC plus CAP group versus 40% in the EUC 
alone group, and for the con tinuous primary outcome of 
daily alcohol consumption, we had a 93% power to detect 
an eﬀ ect size of 0·45.
Analyses were on an intention-to-treat basis, with 
multiple imputation for missing outcome data assuming 
data were missing at random, assuming predictive mean 
matching for positively skewed outcomes. We assessed 
serious adverse events in the per-protocol population. We 
estimated the primary continuous outcome (mean daily 
ethanol consumed in the past 14 days) by multiplying the 
total standard drinks27 consumed in the past 14 days by 10 
(based on the WHO deﬁ nition of a standard drink as 10 g 
73 887 patients assessed for eligibility 
16 007 eligible for screening
57 880 ineligible
679 AUDIT score 12–19
14 094 ineligible
 13 888 AUDIT score <12
 206 AUDIT score >20
14 773 screened with AUDIT
1234 refused
378 enrolled and randomised
188 assigned EUC plus CAP 190 assigned EUC alone
164 with 3 month follow-up 172 with 3 month follow-up
301 declined to participate
24 lost to follow-up
 16 inability to track down the 
  participant
 8 refusals
17 lost to follow-up
 10 inability to track down the 
  participant
 4 refusals
 3 deaths
1 excluded after randomisation because
 erroneously enrolled in both CAP and
   HAP trials
188 included in intention-to-treat analysis 189 included in intention-to-treat analysis
 Figure 1: Trial proﬁ le
AUDIT=Alcohol Use Disorders Identiﬁ cation Test. CAP=Counselling for Alcohol Problems. EUC=enhanced usual 
care. HAP=Healthy Activity Program.
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of pure ethanol28). We used zero-inﬂ ated negative binomial 
regression29 to estimate the intervention eﬀ ect for this 
outcome and other positively skewed overdispersed 
outcomes with an excess of zeros. We analysed continuous 
outcomes with normally distributed residuals using linear 
regression. We analysed binary outcomes using logistic 
regression.
We adjusted all models for both PHC as a ﬁ xed eﬀ ect to 
allow for within-PHC clustering and for baseline AUDIT 
score. As only ten PHCs were included in the study, we 
decided to adjust for these PHCs as ﬁ xed eﬀ ects, as 
recommended by Kahan30 for studies with a small 
number of centres. However, we did a sensitivity analysis 
using random-eﬀ ects models to adjust for within-PHC 
clustering. Additionally, we did a post-hoc analysis 
allowing for clustered errors using the cluster option in 
Stata. For outcomes analysed with use of zero-inﬂ ated 
negative binomial regression, the intervention eﬀ ect is 
estimated for all participants in one model as an adjusted 
odds ratio with a 95% CI for the proportion with zero 
(ie, no reported drinking) and an adjusted count ratio 
with a 95% CI among those with non-zero responses. For 
other continuous outcomes, we reported the intervention 
eﬀ ect as the adjusted mean diﬀ erence with a 95% CI. For 
binary outcomes, we reported the intervention eﬀ ect as 
the adjusted prevalence ratio and adjusted prevalence 
diﬀ erence, estimated using the marginal standardisation 
technique with a 95% CI for the prevalence ratios 
estimated using the δ method.31 We assessed moderators 
of treatment eﬀ ect for a-priori-deﬁ ned moderators, 
namely baseline severity of drinking, readiness to 
change, and expectations of the usefulness of counselling. 
Sensitivity analyses for linear and logistic regression 
models were adjustment for counsellor as a random 
eﬀ ect, and complete case analysis. We describe results in 
terms of the strength of evidence rather than statistical 
signiﬁ cance,32 and the consistency of results for related 
outcomes are examined to interpret ﬁ ndings.
We did economic assessments (comparative analysis of 
costs and outcomes between EUC plus CAP and EUC 
alone groups) from the health-care system and societal 
viewpoints. We estimated the costs of CAP by attaching 
appropriate local Indian unit costs to each resource 
required to deliver each component of the intervention, 
including training, supervision, travel, and materials. We 
also collected detailed information about total counsellor 
time for all attempted and completed contacts, including 
travel time, valued using actual counsellor salaries. We 
used the Client Service Receipt Inventory to record 
participants’ subsequent contacts with health services, 
including hospital inpatient and outpatient contacts, and 
also to document any patient-borne or family-borne 
costs, including time out of their usual occupation. We 
valued time out of usual occupation for patients and their 
families using relevant published mean wages.
We compared changes in principal outcomes with 
changes in costs to calculate Incremental Cost 
Eﬀ ective ness Ratios (ICERs). We calculated cost per 
additional remission or non-drinker achieved and 
quality-adjusted life-year (QALY) gained. We compared 
diﬀ erences in mean costs using standard parametric 
tests. We derived QALY scores through transformation of 
WHODAS II 12 item scores.33 We imputed missing 
values for QALYs and cost data and bootstrapped ICERs 
to derive 95% CIs. We explored statistical uncertainty 
around the ICERs through cost-eﬀ ectiveness acceptability 
curves showing the likelihood that CAP would be cost-
eﬀ ective at diﬀ erent levels of willingness-to-pay 
thresholds. All costs are presented in 2015 international 
dollars. We did statistical analyses using Stata version 14.1. 
A Data and Safety Monitoring Committee oversaw the 
trial. This trial is registered with the ISCRTN registry, 
number ISRCTN76465238.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. VP, HAW, AN, BW, DM, A-LP, and BB had full 
access to all the data in the study. VP, AN, and BW had ﬁ nal 
responsibility for the decision to submit for publication.
EUC plus CAP 
(n=188)
EUC alone
(n=189)
Age (years) 42·3 (11·8) 41·7 (10·9)
Marital status
Married 147 (78%) 154 (81%)
Single 38 (20%) 32 (17%)
Separated, divorced, or 
widowed
3 (2%) 3 (2%)
Occupation
Unemployed 25 (13%) 28 (15%)
Unskilled manual labour 131 (70%) 135 (71%)
Skilled manual labour 13 (7%) 12 (6%)
Clerical and professional 19 (10%) 14 (7%)
Education
No formal education 41 (22%) 29 (15%)
Completed primary 
education
90 (48%) 107 (57%)
Completed secondary 
education or higher
57 (30%) 53 (28%)
Patient’s expectation of usefulness of counselling
Not useful 1 (1%) 2 (1%)
A little or somewhat useful 36 (19%) 39 (21%)
Moderately useful 42 (22%) 38 (20%)
Very useful 109 (58%) 110 (58%)
AUDIT score
Mean 14·7 (2·1) 15 (2·1)
Median 14 (13–16) 15 (13–17)
Data are mean (SD), n (%), or median (IQR).
Table 1: Baseline characteristics 
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Results
Between Oct 28, 2013, and July 29, 2015, we assessed 
73 887 PHC attenders for eligibility (ﬁ gure 1). Of these, 
16 007 (22%) were eligible for screening and 14 773 (92%) 
of these were screened with AUDIT. Of these, 679 (5%) 
screened positive as harmful drinkers and 378 (56%) of 
these consented to participate and were enrolled and 
randomly allocated (188 [50%] to the EUC plus CAP 
group and 190 [50%] to the EUC alone group, one of 
whom was subsequently excluded from the EUC alone 
group because he was erroneously enrolled in both CAP 
and HAP trials, leaving a total of 189 patients in the EUC 
alone group). The leading reasons for ineligibility for 
screening included age younger than 18 years or older 
than 65 years (23 453 [41%] of 57 880), already having 
been screened within the last 3 months (10 046 [17%]), 
not planning to be resident in the study area for the 
duration of the study (9835 [17%]), and being resident 
outside of the study catchment areas (6014 [10%]). The 
trial ended on Aug 30, 2016, when the 12 month outcome 
assessment ended.
Baseline characteristics were similar between groups 
(table 1). We noted no signiﬁ cant diﬀ erence in age 
between participants and those who declined participation 
(mean age 42·0 years [SD 11·4] vs 40·5 years [11·7]; 
p=0·09), with a higher AUDIT (median AUDIT score 14 
[IQR 13–16] vs 14 [13–16]; p=0·04) and PHQ-9 (median 
PHQ-9 score 4 [IQR 1–8] vs 3 [1–6]; p<0·0001) score. 
Participation by PHC varied signiﬁ cantly (p=0·001), with 
higher parti cipation in some PHCs (>60%) rather than 
others (<60%; appendix). Of the 377 participants, 336 
(89%) were seen at the primary endpoint of 3 months (164 
[44%] in the EUC plus CAP group and 172 [46%] in the 
EUC alone group), a ﬁ gure similar to the number 
predicted for the sample size estimation. Participants 
who were lost to follow-up tended to be younger than 
were those not lost to follow-up (appendix). Reasons for 
loss to follow-up were inability to track down the 
participant (26 [63%] of 41; 16 [39%] in the EUC plus CAP 
group vs ten [24%] in the EUC alone group), refusal (12 
[29%]; eight [20%] vs four [10%]), and death (three [7%] in 
the EUC alone group). We imputed outcome data for 
these 41 participants lost to follow-up.
The proportion with remission according to AUDIT 
was signiﬁ cantly higher in the EUC plus CAP group than 
in the EUC alone group (59 [36%] of 164 scoring less 
than 8 on AUDIT in the EUC plus CAP group vs 44 [26%] 
of 172 in the EUC alone group; adjusted prevalence ratio 
1·50 [95% CI 1·09–2·07]; p=0·01; adjusted prevalence 
diﬀ erence 12·6% [5·9–27·1]; table 2). Analysis of daily 
ethanol consumption showed a signiﬁ cantly higher 
proportion of participants reporting no alcohol con-
sumption in the past 14 days in the EUC plus CAP group 
than in the EUC alone group (68 [41%] in the EUC plus 
CAP group vs 31 [18%] in the EUC alone group; adjusted 
odds ratio 3·00 [95% CI 1·76–5·13]; p<0·0001) and no 
diﬀ erence in consumption among those who reported 
any drinking in this period (37·0 g [SD 44·2] vs 31·0 g 
[27·8]; count ratio 1·08 [95% CI 0·79–1·49]; p=0·62).
We noted no evidence of an intervention eﬀ ect on SIP 
score, WHODAS II score, days unable to work, suicide 
attempts, perpetration of intimate partner violence, and 
percentage of days of heavy drinking. We did note a 
signiﬁ cant intervention eﬀ ect on the per centage of days 
abstinent in the past 14 days. We noted no evidence of 
eﬀ ect modiﬁ cation by baseline AUDIT score (ﬁ gure 2) or 
expectations of the usefulness of counselling (appendix). 
However, we found evidence of a greater intervention 
eﬀ ect among those not already trying to change drinking 
behaviour at baseline for ethanol consumption (p=0·003) 
than among those already trying. Results were similar 
when adjusted for counsellor as a random eﬀ ect, when 
using complete case analyses, and when allowing for 
clustered errors. We noted no signiﬁ cant diﬀ erences in 
the number of serious adverse events between the two 
groups (any serious adverse event six [4%] in the EUC plus 
CAP group vs 13 [8%] in the EUC alone group, p=0·11; 
death none vs three [2%], p=0·25; suicide attempts none vs 
EUC plus CAP 
(n=164)*
EUC alone 
(n=172)*
Intervention eﬀ ect 
(95% CI)†
p value
Primary outcomes
Remission (AUDIT score of <8) 59 (36%) 44 (26%) aPR 1·50 (1·09–2·07) 0·01
Daily standard ethanol 
consumed in the past 14 days‡
Non-drinkers 68 (41%) 31 (18%) aOR 3·00 (1·76–5·13) <0·0001
Ethanol consumption among 
drinkers (g)
37·0 (44·2) 31·0 (27·8) Count ratio 1·08 
(0·79–1·49)
0·62
Secondary outcomes
SIP score 7·9 (9·1) 8·2 (8·9) AMD –0·03 
(–1·93 to 1·86)
0·97
WHODAS II score 4·4 (6·2) 3·5 (5·3) AMD 0·62 
(–0·62 to 1·87)
0·32
Days unable to work‡
None 109 (66%) 117 (68%) aOR 1·02 (0·61–1·69) 0·95
Days unable to work when at 
least 1 day reported
11·5 (10·4) 11·2 (10·1) Count ratio 0·92 
(0·59–1·43)
0·70
Number of suicide attempts 0 3 (2%) aOR 0; aPR 1·8 
(–2·4 to 6·0)
0·25
Perpetration of intimate 
partner violence§
12/127 (9%) 16/140 (11%) aOR 0·81 (0·39–1·67); 
aPR 3·0 (–10·4 to 4·4)
0·57
Percentage of days abstinent 69·4% (37·3) 54·4% (36·3) AMD 16·0% (8·1 to 24·1) <0·0001
Percentage of days of heavy 
drinking
9·5% (2·5) 10·0% (2·4) AMD –0·4% (–5·7 to 4·9) 0·88
Data are n (%) or mean (SD). EUC=enhanced usual care. CAP=Counselling for Alcohol Problems. AUDIT=Alcohol Use 
Disorders Identiﬁ cation Test. aPR=adjusted prevalence ratio. aOR=adjusted odds ratio. SIP=Short Inventory of 
Problems. AMD=adjusted mean diﬀ erence. WHODAS=WHO Disability Assessment Schedule. *Among those with 
observed data at 3 months. †Including imputed outcome data for those with missing data. ‡Analysed with a 
zero-inﬂ ated negative binomial model that ﬁ ts two parameters in one model—ie, the proportion with response of zero 
(eg, no drinking in 14 days or no days unable to work) and the mean count (eg, ethanol consumption or days unable to 
work) among people with a non-zero (positive) response. §Among married participants only. 
Table 2: Primary and secondary outcomes 
See Online for appendix
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three [1%], p=0·25; unplanned admissions to hospital six 
[4%] vs seven [4%], p=1·00; appendix).
The intraclass correlation for ethanol consumption at 
3 months within PHCs was 0·04, as predicted. Of the 
188 participants in the EUC plus CAP group, 131 (70%) 
had a planned discharge and none were referred for 
specialist care. The mean number of sessions for those 
who had a planned discharge was 2·8 (95% CI 2·7–3·0), 
whereas those who had an unplanned discharge were 
most likely to drop out after the ﬁ rst session (mean 
number of sessions 1·1 [95% CI 1·0–1·3]). Of the total of 
434 sessions delivered, 425 (98%) were delivered in face-
to-face format; 84 (33%) of 257 sessions from the second 
session onwards were delivered at home, and 42 (22%) of 
participants in the EUC plus CAP group had a signiﬁ cant 
other involved in at least one session. The mean duration 
of sessions was 42·4 min (40·9–43·7). Mean TQS score 
on the basis of peer supervisor ratings (n=183) was 2·35 
(2·29–2·41), similar to expert supervisor ratings (n=183; 
mean 2·44 [2·36–2·51]) and the mean score of the 
independent rater for 10% of randomly selected sessions 
(n=40; mean 2·64 [2·42–2·87]), indicating adequate to 
good therapy quality. 13 (3%) of 377 investigators were 
unmasked, with eight (2%) unmasked before the primary 
outcome assessment.
From the health system perspective, the total health-
care cost per person—ie, including the intervention cost, 
was signiﬁ cantly higher in the EUC plus CAP group 
than in the EUC alone group, with no signiﬁ cant 
diﬀ erence in QALY scores (table 3). Excluding 
intervention costs, we noted no signiﬁ cant diﬀ erences in 
aggregate health-care costs. Medication costs were 
signiﬁ cantly lower in the EUC plus CAP group than in 
the EUC alone group. The incremental cost per 
additional remission from a health-care system 
perspective is shown in table 4; as ﬁ gure 3 shows, if 
society is willing to pay up to the monthly minimum 
wage in Goa ($415)34 per individual in remission, CAP 
has an 85% chance of being cost-eﬀ ective. Similarly, the 
cost per additional non-drinker was $124 (95% CI 
–$102 to $325), which would mean that CAP would have 
a more than 99% chance of being considered cost-
eﬀ ective (appendix).
Discussion
This study provides evidence of the eﬀ ectiveness of 
CAP, a brief psychological treatment for harmful 
drinking delivered by NSHWs in routine primary care 
settings. CAP was associated with strong eﬀ ects on 
abstinence and remission 3 months after enrolment, 
but had no eﬀ ect on other alcohol-related outcomes. 
The economic analysis indicates that CAP is likely to be 
cost-eﬀ ective with regard to remission and non-drinking 
outcomes.
Although WHO recommends brief counselling for 
treatment of harmful drinkers,35 almost all evidence in 
support of these recommendations is from high-income 
settings.7 Our results add to the evidence base by showing 
that multisession brief interventions for harmful drinking 
in primary care attenders can be eﬀ ective when delivered 
by well trained and supervised health workers without any 
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Figure 2: Ethanol consumption at 3 months by baseline AUDIT score
AUDIT=Alcohol Use Disorders Identiﬁ cation Test.
EUC plus CAP 
(n=188)
EUC alone 
(n=189)
Mean diﬀ erence 
(95% CI)
p value
Health system costs ($)
PHC doctor consultations $7 (12) $9 (5) –$2 (–5 to 1) 0·11
Hospital doctor consultations $3 (12) $3 (9) –$0 (–2 to 2) 0·77
Hospital admissions $13 (92) $13 (56) $0 (–16 to 14) 0·89
Laboratory tests $4 (9) $6 (21) –$2 (–6 to 0) 0·08
Medicines $4 (10) $7 (18) –$3 (–7 to 1) 0·02
Total public health-care costs $30 (104) $38 (76) –$8 (–26 to 11) 0·40
CAP treatment $33 (30) $0 $33 (2 to 38) <0·0001
Productivity costs ($)
Time costs to service users 
and families
$23 (47) $19 (33) $4 (–6 to 9) 0·80
Productivity losses $53 (110) $64 (119) –$11 (–37 to 9) 0·24
Total costs ($)
Health system perspective $64 (111) $39 (77) $25 (5 to 44) 0·01
Societal perspective $139 (211) $121 (169) $18 (–18 to 59) 0·30
Cost-eﬀ ectiveness analyses
QALYs gained 0·220 (0·013) 0·221 (0·012) –0·001 
(–0·004 to 0·001)
0·29
Data are mean (SD). EUC=enhanced usual care. CAP=Counselling for Alcohol Problems. PHC=primary health centre. 
QALY=quality-adjusted life-year.
Table 3: Costs per person and cost-eﬀ ectiveness analyses (2015 international dollars) 
Health system perspective Societal perspective
Cost per remission ($) $217 (50 to 1073) $150 (–216 to 1051)
Cost per non-drinker ($) $124 (–102 to 325) $86 (29 to 265)
Cost per QALY gained ($)* –$17 710 (–220 368 to 141 383) –$12 267 (–104 070 to 133 648)
Data are mean (95% CI). *Negative values reﬂ ect the lower QALY score and not lower costs.
Table 4: Cost-eﬀ ectiveness analyses from health system and societal perspectives (2015 international 
dollars)
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previous mental health training.36 Only two randomised 
controlled trials37,38 in low-income or middle-income 
countries have tested a NSHW-delivered treatment for any 
form of alcohol use disorder. However, both of these 
previous studies targeted hazardous or binge drinkers, 
and only one37 was based in primary care. Our study is the 
ﬁ rst, to our knowledge, of such an intervention that has 
reported an economic assessment. The CAP treatment is 
a contextually appropriate intervention for harmful 
drinking developed speciﬁ cally to be delivered by lay 
counsellors in primary care settings in low-income or 
middle-income countries, and this study provides 
evidence of eﬀ ectiveness compared with EUC. When wide 
societal eﬀ ects (eg, domestic violence and law enforcement 
costs) and savings for the family are considered, the 
economic case could perhaps be further strengthened. 
Although the economic argument might be a cause for 
action, it needs to be tested in future assessments.
As described above, brief interventions typically involve 
a brief conversation delivered to hazardous drinkers. For 
harmful drinkers, brief therapies focusing on speciﬁ c 
behavioural change strategies, including provision of 
clients with skills to deal with alcohol-related problems, 
might be appropriate.39,40 The CAP treatment seeks to do 
just that. In India, various alcoholic beverages are 
consumed, consisting of commercial, licit non-
commercial, and illicit home-brewed alcoholic beverages.1 
The CAP treatment is designed around assessment, 
personalised feedback, and provision of skills needed to 
manage behaviours related to drinking, irrespective of 
the speciﬁ c type of alcohol consumed. The pattern of 
outcomes suggests that CAP had eﬀ ects on those who 
chose abstinence as a treatment goal, but did not have 
any eﬀ ects on those who chose to continue drinking. 
This ﬁ nding is consistent with the prevailing beliefs 
about the nature of alcohol problems in India, which 
place great importance on abstinence.41 The greater eﬀ ect 
of CAP on those who were not already trying to make a 
change in their drinking behaviour compared with those 
who had already started to make a change indicates that 
the treatment enhanced motivation to change. This 
ﬁ nding is consistent with the motivational enhancement 
theory on which CAP is based.42 CAP did not have any 
signiﬁ cant eﬀ ect on the adverse consequences of alcohol 
use disorder, as shown by the absence of signiﬁ cant 
diﬀ erences in any of the prespeciﬁ ed secondary 
outcomes. One probable reason for this ﬁ nding is that 
the severity of harmful drinking is not great enough to 
register on tools like SIP whose previous use has been 
primarily for people with dependent drinking, and 
consequently, any intervention targeting such drinking 
patterns does not result in observed changes with these 
tools. Finally, changes in outcomes like perpetration of 
domestic violence might possibly require speciﬁ c 
strategies targeting these behaviours, and only targeting 
of drinking as a mediating mechanism might not be 
eﬀ ective in reduction of domestic violence.
The study had several limitations. Reliance on self-
reported outcome data entails susceptibility to social 
desirability bias, and this factor might have varied by 
group.43 Reasons for under-reporting might have 
included the participant actually believing the 
information that they reported (self-deception) or so-
called faking good to conform to socially acceptable 
values, avoid criticism, or gain social approval. However, 
more objective measures such as biomarkers are 
insensitive to alcohol use disorder except for when it is 
severe, and alcohol treatment trials have not found 
advantages in use of collateral reports or other 
alternatives.44 Biomarkers might, in time, be developed 
for use in clinical trials, although at present the most 
promising ones available do not accurately and sensitively 
estimate levels of consumption.45 The results in our study 
are restricted to the primary outcomes at 3 months where 
our interest lies in the response and remission of 
participants with harmful drinking after our treatment. 
We intend to assess the sustainability of these outcomes, 
including recovery from harmful drinking, at a 12 month 
follow-up. No cost-eﬀ ectiveness thresholds have been 
established for alcohol outcomes in India; we have 
conservatively assumed that this threshold is no more 
than the monthly wage for an unskilled worker. The 
absence of eﬀ ect on QALYs might be viewed in the 
context of doubt about the capacity of standard measures 
such as those used in this study to capture improvements 
in alcohol-related quality of life.46 A delayed eﬀ ect of 
reduced drinking or abstinence on QALYs could also be 
possible and we could perhaps expect to see a diﬀ erential 
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eﬀ ect between the two groups at the 12 month outcome 
assessment. Finally, our ﬁ ndings cannot be generalised 
to women as CAP was developed and tested only in men. 
However, none of the content of CAP is sex speciﬁ c and 
in our opinion there is no theoretical reason to believe 
that CAP would not work in women. Nevertheless, as 
alcohol consumption and its resulting problems are 
starting to increase in India, albeit from an extremely 
small base, study of this treatment in female harmful 
drinkers is needed.
The strengths of this trial lie in its design and the 
rigorous procedures followed in its implementation. 
The ratings of therapy quality, both independent and by 
supervisors, and the high levels of treatment completion 
testify to the acceptability and feasibility of this non-
specialist-delivered treatment. Another strength was 
that intensive assessments were not done at baseline as 
assessment reactivity has been found to be problematic 
in alcohol use disorder trials.47,48 Considered together 
with the companion study,17 the two PREMIUM trials 
represent a substantial achievement in global mental 
health for several reasons. First, the interventions are 
brief, delivered by lay people and provided to primary 
health-care attenders with few exclusion criteria, thus 
enhancing their generalisability to routine health care. 
Second, the treatment was delivered by the same 
counsellors who concurrently delivered the treatment 
for depression, mimicking the real world where 
patients would have a single counsellor in a health 
facility simultaneously treating the two leading mental 
health disorders worldwide. Third, the treatments are 
built around a theoretical orientation, which have a 
strong grounding in the psychological treatment 
literature. Finally, the trials report for the ﬁ rst time 
evidence for the cost-eﬀ ectiveness of psychological 
treatments for these two common mental health 
conditions from a low-income or middle-income 
country.
Further research should focus on replication and 
assessment of CAP’s eﬀ ects on severe forms of alcohol 
use disorder, including as a component of a stepped care 
intervention for the full range of severity of alcohol use 
disorder. Our dissemination eﬀ orts for CAP include 
launching of an online platform for those interested to 
learn about the treatment49 and an online documentary 
about the PREMIUM trials.50
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